Sorafenib

98%

  • Product Code: 103493
  Alias:    Sorafenib p-toluenesulfonate; Sorafenib; Sorafenib; Sora+E51 Rani; NEXAVAR;
  CAS:    284461-73-0
Molecular Weight: 464.83 g./mol Molecular Formula: C₂₁H₁₆ClF₃N₄O₃
EC Number: MDL Number:
Melting Point: 202-204°C Boiling Point: 523.3ºC
Density: 1.454 g/cm3 Storage Condition: room temperature
Product Description: Sorafenib is primarily used as a targeted therapy in the treatment of advanced renal cell carcinoma (kidney cancer), hepatocellular carcinoma (liver cancer), and differentiated thyroid carcinoma. It works by inhibiting multiple kinases involved in tumor growth and angiogenesis, thereby slowing the progression of these cancers. In liver cancer, it is often prescribed when surgical options are not viable. For kidney cancer, it is used when the disease has spread or become resistant to other treatments. In thyroid cancer, it is employed for cases that are no longer responsive to radioactive iodine therapy. The drug is administered orally, allowing for convenient outpatient treatment, and is typically taken twice daily. Regular monitoring is required to manage potential side effects, such as hypertension, skin reactions, and gastrointestinal issues.
Product Specification:
Test Specification
Purity (%) 97.5-100
Appearance White To Gray Powder
Sizes / Availability / Pricing:
Size (g) Availability Price Quantity
1.000 10-20 days ฿500.00
+
-
5.000 10-20 days ฿1,820.00
+
-
25.000 10-20 days ฿6,030.00
+
-
100.000 10-20 days ฿18,350.00
+
-
Sorafenib
Sorafenib is primarily used as a targeted therapy in the treatment of advanced renal cell carcinoma (kidney cancer), hepatocellular carcinoma (liver cancer), and differentiated thyroid carcinoma. It works by inhibiting multiple kinases involved in tumor growth and angiogenesis, thereby slowing the progression of these cancers. In liver cancer, it is often prescribed when surgical options are not viable. For kidney cancer, it is used when the disease has spread or become resistant to other treatments. In thyroid cancer, it is employed for cases that are no longer responsive to radioactive iodine therapy. The drug is administered orally, allowing for convenient outpatient treatment, and is typically taken twice daily. Regular monitoring is required to manage potential side effects, such as hypertension, skin reactions, and gastrointestinal issues.
Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Cart

No products

Subtotal: ฿0.00
฿0.00 Total :

The availability date depends on real-time stock, and any changes after payment will be notified within 30 minutes
You can choose the delivery date on the next page